SCHEMBL8947849

SCHEMBL8947849

O=CC1CCC2OC(=O)CC12

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8947855 1.00 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL13595438 1.00 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL8411037 1.00 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL8947846 1.00 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL11459579 1.00 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL10047143 1.00 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL18388406 0.82 PRSS1 (0.38) SMN1; SMN2
SCHEMBL9471099 0.82 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL14729803 0.78 — —
SCHEMBL12808379 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 — — US disclosed
US-5486540-A Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents ALLERGAN, INC. (US) 1996-01-23 — — US disclosed
US-4596823-A Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-06-24 — — US disclosed
EP-0043292-B1 PROSTAGLANDINS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-01-15 — — EP disclosed
US-4410720-A HYPOTENSIVE AGENTS HOFFMANN-LA ROCHE INC. (US) 1983-10-18 — — US disclosed
US-4256911-A TRIFLUOROMETHYL-CARBOXY ESTERS HOFFMANN-LA ROCHE INC. (US) 1981-03-17 — — US disclosed
US-4246426-A USEFUL IN INDUCING LABOR, TERMINATING PREGNANCY, TREATING GASTRIC HYPERACIDITY, WITH CARDIOVASCULAR AND BRONCHODILATOR EFFECTS HOFFMANN-LA ROCHE INC. (US) 1981-01-20 — — US disclosed
US-4246402-A CARDIOVASCULAR AGENTS AND OXYTOCICS HOFFMANN-LA ROCHE INC. (US) 1981-01-20 — — US disclosed
US-4237276-A CARDIOVASCULAR AGENTS, INDUCTION OF LABOR, TERMINATION OF PREGNANCY HOFFMANN-LA ROCHE INC. (US) 1980-12-02 — — US disclosed
US-4227019-A CARDIOTONIC AGENTS; OXYTOCICS HOFFMANN-LA ROCHE INC. (US) 1980-10-07 — — US disclosed
US-4211724-A ENANTIOMORPHS, INTERMEDIATE AMIDES WITH ASSYMETRIC CARBON ATOM HOFFMAN-LA ROCHE INC. (US) 1980-07-08 — — US disclosed
US-4190587-A PROSTAGLANDINS HOFFMANN-LA ROCHE INC. (US) 1980-02-26 — — US disclosed
US-4187381-A CARDIOVASCULAR AGENTS; OXYTOCICS HOFFMANN-LA ROCHE INC. (US) 1980-02-05 — — US disclosed
US-4130721-A 11-Deoxy PGE2 compounds THE UPJOHN COMPANY (US) 1978-12-19 — — US disclosed
US-4112225-A 16-CF3 prostaglandins HOFFMAN-LA ROCHE INC. (US) 1978-09-05 — — US disclosed
US-4059576-A CARDIOVASCULAR, OXYTOCICS HOFFMANN-LA ROCHE, INC. (US) 1977-11-22 — — US disclosed
US-4052446-A OXYTOCICS, CARDIOVASCULAR AGENTS HOFFMANN-LA ROCHE INC. (US) 1977-10-04 — — US disclosed
US-3931279-A 5-Oxa prostaglandin F2.sub.α analogs THE UPJOHN COMPANY (US) 1976-01-06 — — US disclosed
Send feedback